These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 726877)

  • 1. Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.
    Dalén N; Furuhjelm M; Jacobson B; Lamke B
    Acta Obstet Gynecol Scand; 1978; 57(5):435-7. PubMed ID: 726877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
    Staland B
    Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
    Dören M; Reuther G; Minne HW; Schneider HP
    Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
    Mattsson LA; Abrahamsson L; Cullberg G; Samsioe G
    Arch Gynecol; 1983; 233(2):101-7. PubMed ID: 6683955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
    Christiansen C; Rødbro P
    Calcif Tissue Int; 1983 Sep; 35(6):720-2. PubMed ID: 6652546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
    Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
    Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
    Resch H; Pietschmann P; Krexner E; Woloszczuk W; Willvonseder R
    Acta Endocrinol (Copenh); 1990 Jul; 123(1):14-8. PubMed ID: 2389624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A; Christiansen C; Transbøl I
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kliogest--the possibility of hormonal substitution in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photon absorptiometry studies in osteoporosis.
    Christiansen C
    Acta Obstet Gynecol Scand Suppl; 1985; 130():67-70. PubMed ID: 3893022
    [No Abstract]   [Full Text] [Related]  

  • 19. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.